WILSON DISEASE
(ATP7B H1069Q MUTATION)
Background
Wilson’s disease is an autosomal-recessive disorder caused by mutation in the ATP7B gene, with resultant impairment of biliary excretion of copper. Subsequent copper accumulation, first in the liver but ultimately in the brain and other tissues, produces protean clinical manifestations that may include hepatic, neurological, psychiatric, ophthalmological, and other derangements.
The most common mutation in patients from Central, Eastern, and Northern Europe is the point mutation H1069Q. About 50–80% of Wilson disease (WD) patients from these countries carry at least one allele with this mutation with an allele frequency ranging between 30 and 70% .
Literatur:
-
New Genetic Tests
- Clopidogrel Resistance (CYP2C19)
- Statin Side-Effects (SLCO1B1)
- Morbus Wilson (ATP7B)